EV

Elikon Venture

Asia, Shanghai, China, Shanghai

Description

Elikon Venture is a venture capital firm.

Investor Profile

Elikon Venture has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Medical, Pharmaceutical, Therapeutics.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Elikon Venture frequently co-invest with?

INCE Capital
Asia, Shandong, China, Pudong
Co-Investments: 1
Med-Fine Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
OC
North America, New York, United States, New York
Co-Investments: 1
TF Capital
Asia, Shandong, China, Pudong
Co-Investments: 2
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 1
3SBio Inc.
Asia, Liaoning, China, Shenyang
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Firstred Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Elikon Venture?

Angitia Biopharmaceuticals

Westlake Village, California, United States

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

BiopharmaBiotechnologyHealth CareMedical
Series DFeb 5, 2026
Amount Raised: $130,000,000
Fortitude Biomedicines

Waltham, Massachusetts, United States

Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases.

BiotechnologyMedical
SeedJan 26, 2026
Amount Raised: $13,000,000
Oricell Therapeutics

Shanghai, Shanghai, China

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Health CarePharmaceuticalProduct Research
Series CJan 12, 2026
Amount Raised: $70,000,000
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series CDec 11, 2024
Amount Raised: $120,000,000
Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics
Series BMar 9, 2023
Amount Raised: $50,000,000
Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics
Series ANov 24, 2021
Amount Raised: $40,000,000

Find More Investors Like Elikon Venture

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Elikon Venture | Pipeseed